{"product_id":"internal-medicine-for-primary-care-addiction-gynecology-neurology-palliative-2025","title":"Internal Medicine for Primary Care: Addiction\/Gynecology\/Neurology\/Palliative 2025 (Videos with subtitles + Slides)","description":"\u003ch3\u003eINTERNAL MEDICINE FOR PRIMARY CARE: ADDICTION\/GYNECOLOGY\/NEUROLOGY\/PALLIATIVE\u003c\/h3\u003e\n\u003ch4\u003eOahu, HI - Aulani, A Disney Resort \u0026amp; Spa\u003cbr\u003eJune 15 - 19, 2025\u003c\/h4\u003e\n\u003ch3\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/h3\u003e\u003cbr\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine\u003cbr\u003e\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\u003cbr\u003eUpon completion of this program, participants should be better able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e- Perform a neurological exam\u003c\/li\u003e\n\u003cli\u003e- Utilize history and physical examination to distinguish weakness from non-specific symptoms\u003c\/li\u003e\n\u003cli\u003e- Describe the differential diagnosis of headaches and migraines\u003c\/li\u003e\n\u003cli\u003e- Discuss evidence-based management options for Alzheimer’s disease\u003c\/li\u003e\n\u003cli\u003e- Evaluate weakness and recognize cardinal features of Parkinson's disease as well as other movement disorders\u003c\/li\u003e\n\u003cli\u003e- List details about the Medicare hospice benefit\u003c\/li\u003e\n\u003cli\u003e- Describe the primary care approach to palliative medicine including symptom management\u003c\/li\u003e\n\u003cli\u003e- Recognize the importance of prognosis in decision making for seriously ill patients\u003c\/li\u003e\n\u003cli\u003e- Define and establish goals of care with patients and their families\u003c\/li\u003e\n\u003cli\u003e- Discuss pain management options with both nonopioid and opioid medications\u003c\/li\u003e\n\u003cli\u003e- Describe the neurobiology of addiction\u003c\/li\u003e\n\u003cli\u003e- Discuss options for patients with chronic pain addictions\u003c\/li\u003e\n\u003cli\u003e- Identify therapies, including nonpharmacological pain treatment strategies, that can reduce the dose of opioids to control pain\u003c\/li\u003e\n\u003cli\u003e- Develop a treatment plan for Alcohol Use Disorder\u003c\/li\u003e\n\u003cli\u003e- Apply evidence-based treatment strategies to chronic brain disorders affecting behavioral addictions\u003c\/li\u003e\n\u003cli\u003e- Assess and manage abnormal uterine bleeding\u003c\/li\u003e\n\u003cli\u003e- Discuss menopausal transition and the risks\/benefits of treatment options\u003c\/li\u003e\n\u003cli\u003e- Describe the management of HPV infection and abnormal pap smear results\u003c\/li\u003e\n\u003cli\u003e- Identify evidence-based tools to determine best practices in incorporating all necessary elements in the annual women's health visit\u003c\/li\u003e\n\u003cli\u003e- Discuss modern methods of fertility, natural family planning and contraception\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eAgenda \u0026amp; Learning Objectives\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTime\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eSession Title\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eTopic\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDescription\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cb\u003eSunday, June 15, 2025\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:30 pm\u003c\/td\u003e\n\u003ctd\u003eRegistration\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:00 pm - 4:00 pm\u003c\/td\u003e\n\u003ctd\u003eThe Neurological Exam\u003c\/td\u003e\n\u003ctd\u003eNeurology\u003c\/td\u003e\n\u003ctd\u003eCharacteristics and objectives of the examination; exam phases; assessing general mental status; long-term predications; examination of infants; demonstration on conducting an exam.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:00 pm - 5:00 pm\u003c\/td\u003e\n\u003ctd\u003eEvaluating Weakness\u003c\/td\u003e\n\u003ctd\u003eNeurology\u003c\/td\u003e\n\u003ctd\u003eUsing the history and physical examination to distinguish weakness from non-specific symptoms; characteristics of neurological diseases that produce weakness; presentations of representative diseases of the nervous system.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:00 pm - 6:00 pm\u003c\/td\u003e\n\u003ctd\u003eHeadaches \u0026amp; Migraines\u003c\/td\u003e\n\u003ctd\u003eNeurology\u003c\/td\u003e\n\u003ctd\u003e\n\u003cspan class=\"citation-118 citation-end-118\"\u003eBasic headache mechanisms; headache history: characteristics, precipitating factors, medical conditions; migraine: common tension, classic, treatment, complicated, cluster, sinus; trigeminal neuralgia; Giant Cell Arteritis; brain tumor; subarachnoid hemorrhage; emergency room t\u003c\/span\u003ereatment.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:00 pm\u003c\/td\u003e\n\u003ctd\u003eSession Adjourns\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cb\u003eMonday, June 16, 2025\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 am\u003c\/td\u003e\n\u003ctd\u003eRegistration and Hot Breakfast\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30 am - 8:30 am\u003c\/td\u003e\n\u003ctd\u003eMedicare Hospice Benefit\u003c\/td\u003e\n\u003ctd\u003ePalliative\u003c\/td\u003e\n\u003ctd\u003eWhich patients are eligible? What is palliative care? What does the Medicare benefit provide for patients and families?\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30 am - 9:30 am\u003c\/td\u003e\n\u003ctd\u003eSymptom Management\u003c\/td\u003e\n\u003ctd\u003ePalliative\u003c\/td\u003e\n\u003ctd\u003eSymptom management; Symptom management of dyspnea and cough, pain, nausea and vomiting, constipation, and agitation, at the end of life.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:30 am - 9:40 am\u003c\/td\u003e\n\u003ctd\u003eCoffee Break\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:40 am - 10:40 am\u003c\/td\u003e\n\u003ctd\u003ePrognostication for the PCP\u003c\/td\u003e\n\u003ctd\u003ePalliative\u003c\/td\u003e\n\u003ctd\u003eEstimating life expectancy for patients with life-limiting illnesses such as CHF, Alzheimer’s dementia, Parkinson’s disease, end stage renal disease.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:40 am - 11:40 am\u003c\/td\u003e\n\u003ctd\u003eAlzheimer’s \u0026amp; Other Dementias\u003c\/td\u003e\n\u003ctd\u003eNeurology\u003c\/td\u003e\n\u003ctd\u003eDefinition; statistics; neurological changes of normal aging; pathology; etiological theories; vascular dementias; investigations; social issues; symptomatic treatment; research therapies.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40 am - 12:40 pm\u003c\/td\u003e\n\u003ctd\u003eParkinson's Disease \u0026amp; Other Movement Disorders\u003c\/td\u003e\n\u003ctd\u003eNeurology\u003c\/td\u003e\n\u003ctd\u003eEpidemiology; cardinal features; secondary features; pathology; neurochemistry; differential diagnosis; treatment; complication; other movement disorders; neuroleptic- induced movement disorders; chorea.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:40 pm\u003c\/td\u003e\n\u003ctd\u003eSession Adjourns\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cb\u003eTuesday, June 17, 2025\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 am\u003c\/td\u003e\n\u003ctd\u003eRegistration and Hot Breakfast\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30 am - 8:30 am\u003c\/td\u003e\n\u003ctd\u003eAddiction 101\u003c\/td\u003e\n\u003ctd\u003eAddiction\u003c\/td\u003e\n\u003ctd\u003eThis module will introduce the disease model of addiction, its neurobiology, and some of the toolseasily used in the primary care setting to identify who is at risk for addiction.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30 am - 9:30 am\u003c\/td\u003e\n\u003ctd\u003eChronic Pain and Addiction\u003c\/td\u003e\n\u003ctd\u003eAddiction\u003c\/td\u003e\n\u003ctd\u003e\n\u003cspan class=\"citation-117 citation-end-117\"\u003eEpidemiology of pain; risk factors and comorbidity; pain management concepts; patient factors affecting the analgesic response; the relationship between stress and chronic pain; the range of therapeutic options for management incl\u003c\/span\u003euding non-pharmacologic approaches.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:30 am - 9:40 am\u003c\/td\u003e\n\u003ctd\u003eCoffee Break\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:40 am - 10:40 am\u003c\/td\u003e\n\u003ctd\u003eOpioid Use Disorder\u003c\/td\u003e\n\u003ctd\u003eAddiction\u003c\/td\u003e\n\u003ctd\u003eUpdate on the opioid crisis; Risk for opioid misuse and addiction; FDA approved medication for treating overdose; FDA approved medication-assisted treatment (MAT) for managing opioid addiction.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:40 am - 11:40 am\u003c\/td\u003e\n\u003ctd\u003eAddressing Goals of Care\u003c\/td\u003e\n\u003ctd\u003ePalliative\u003c\/td\u003e\n\u003ctd\u003eDefinition of POA, DNR, DNI, DNH, MOLST, POLST; Techniques on how to address goals of care, both in acute crisis as well as when the patient has chronic issues.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40 am - 12:40 pm\u003c\/td\u003e\n\u003ctd\u003ePain Management in the Palliative Care Patient\u003c\/td\u003e\n\u003ctd\u003ePalliative\u003c\/td\u003e\n\u003ctd\u003eTreatment of pain with both nonopioid and opioid medications; New guidelines related to opioid prescribing; Side effects management.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:40 pm\u003c\/td\u003e\n\u003ctd\u003eSession Adjourns\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cb\u003eWednesday, June 18, 2025\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 am\u003c\/td\u003e\n\u003ctd\u003eRegistration and Continental Breakfast\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30 am - 8:30 am\u003c\/td\u003e\n\u003ctd\u003eAbnormal Uterine Bleeding\u003c\/td\u003e\n\u003ctd\u003eGynecology\u003c\/td\u003e\n\u003ctd\u003eOverview of normal\/abnormal menstrual physiology\/profile; Menstrual disturbances; Ovulatory and anovulatory uterine bleeding; Other menstrual abnormalities; Diagnosis and appropriate treatment options.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30 am - 9:30 am\u003c\/td\u003e\n\u003ctd\u003eMenopause Transition and Hormone Replacement Therapy\u003c\/td\u003e\n\u003ctd\u003eGynecology\u003c\/td\u003e\n\u003ctd\u003eSymptoms of menopause, including hot flashes, \u003cspan class=\"citation-116 citation-end-116\"\u003enight sweats, and atrophy; Menopause syndromes, including osteoporosis, breast cancer, cardiac disease, and colon cancer; Estrogen analogs; Counseling patients in options and alternatives to hormone therapy; Designer estrogens; SERMs; HRTs; Discussion of risks and benefits, especially in breast canc\u003c\/span\u003eer and CHD.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:30 am - 9:40 am\u003c\/td\u003e\n\u003ctd\u003eCoffee Break\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:40 am - 10:40 am\u003c\/td\u003e\n\u003ctd\u003eCervical Cancer Screening Including HPV Management\u003c\/td\u003e\n\u003ctd\u003eGynecology\u003c\/td\u003e\n\u003ctd\u003e\n\u003cspan class=\"citation-115 citation-end-115\"\u003eCurrent recommendations for cervical cancer screening; incorporating the ASCCP consensus guidelines for management of cytologic cervical abnormalities (including ASCUS, LGSIL, HGSIL and atypical glandular cells) i\u003c\/span\u003ento practice; Algorithm for the appropriate use of HPV testing and managing results; Determining appropriate candidates for the use of the HPV vaccine.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:40 am - 11:40 am\u003c\/td\u003e\n\u003ctd\u003eAlcohol \u0026amp; Benzodiazepines\u003c\/td\u003e\n\u003ctd\u003eAddiction\u003c\/td\u003e\n\u003ctd\u003eThe scope of alcohol related problems and the societal burden of Alcohol Use Disorder; Overview of FDA-approved and more common off-label pharmacotherapies for Alcohol Use Disorder.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40 am - 12:40 pm\u003c\/td\u003e\n\u003ctd\u003eGaming, Gambling \u0026amp; Social Media\u003c\/td\u003e\n\u003ctd\u003eAddiction\u003c\/td\u003e\n\u003ctd\u003eBehavioral addictions to gaming, gambling and social media are poorly understood and thus underdiagnosed and under-treated. They are chronic brain disorders with specific risk factors and require appropriate screening, diagnosis and evidence-based treatment.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:40 pm\u003c\/td\u003e\n\u003ctd\u003eSession Adjourns\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cb\u003eThursday, June 19, 2025\u003c\/b\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 am\u003c\/td\u003e\n\u003ctd\u003eRegistration and Continental Breakfast\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30 am - 8:30 am\u003c\/td\u003e\n\u003ctd\u003eAnnual Exam for Women\u003c\/td\u003e\n\u003ctd\u003eGynecology\u003c\/td\u003e\n\u003ctd\u003eBest practices in offering annual pelvic examinations in asymptomatic non-pregnant \u003cspan class=\"citation-114 citation-end-114\"\u003ewomen; Determination of who should be offered a clinical breast exam as a routine part of the annual women's health exam; The principal elements of the annual women's health visit: screening, vaccinations, evaluation of health risks and needs, counseling; Evidence-based tools to guide components of the annual women's health visit based on age and health nee\u003c\/span\u003eds.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30 am - 9:30 am\u003c\/td\u003e\n\u003ctd\u003eFertility Awareness and Management\u003c\/td\u003e\n\u003ctd\u003eGynecology\u003c\/td\u003e\n\u003ctd\u003eComprehensive review and strategies to apply the physiologic knowledge of the menstrual cycle to clinical situations; Analysis of information about peak fertility times; Comparison and contrast of modern methods of fertility awareness and contraception.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:30 am\u003c\/td\u003e\n\u003ctd\u003eConference Adjourns\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954494214242,"sku":"MED-AMB04547","price":180.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Internal-Medicine-for-Primary-Care-Addiction-Gynecology-Neurology-Palliative-2025.webp?v=1779377975","url":"https:\/\/meducourse.com\/products\/internal-medicine-for-primary-care-addiction-gynecology-neurology-palliative-2025","provider":"Meducourse","version":"1.0","type":"link"}